Search for grants with us!
Grants you might be eligible for
Laboratorium Innowatora – oferta dla pomysłodawców
Laboratorium Innowatora
Programme: Fundusze Europejskie dla Nowoczesnej Gospodarki
General Overview
Organizational Aspects
Funding
Up to 50000.00 PLN
Deadline
April 30, 2026, 11:59 p.m.
Advanced Agricultural Monitoring and Management Solutions
1-10494
Programme: ESA Business Applications
Up to None EUR
Aug. 29, 2025, 9:59 p.m.
Call for Proposals (Non-Competitive) ESA-STAR Reference 1-10494: Space for Sustainability in Sports and Mass Events
Oct. 10, 2025, 9:59 p.m.
Coastal Resilience to Climate Change initiative - ESA Call for Proposals
Oct. 31, 2025, 9:59 p.m.
Space for Olympic Games - Thematic Call under ESA AO/1-10494
Programme: ARTES Business Applications
1. General Overview
2. Organizational Aspects
Dec. 31, 2025, 10:59 p.m.
ESA Kick-Start Activity
6-60007
Programme: BASS ARTES 4.0
Up to 75000.00 EUR
Oct. 31, 2025, 11:59 p.m.
Space for Monitoring Hazardous Materials
ESA Kick-start Activity 2025
Sept. 18, 2025, 9:59 p.m.
Call for Proposals 1-10494: Feasibility Studies and Demonstration Projects for Smart Cities
Sept. 30, 2025, 9:59 p.m.
ESA Call for Proposals 1-10494: Space for Intermodal Transport
Sept. 12, 2025, 9:59 p.m.
Translational Neural Devices (R61/R33 - Clinical Trial Optional)
PAR-25-053
Programme: NIH Grants
GRANT OVERVIEW
ELIGIBILITY CRITERIA
Up to None USD
Jan. 28, 2027, 10 p.m.
BRAIN Initiative: Reagent Resources for Brain Cell Type-Specific Access
RFA-MH-26-120
Programme: BRAIN Initiative
June 15, 2027, 10 p.m.
Networks of European Cinemas
CREA-MEDIA-2025-CINNET
Programme: Creative Europe Programme
The CREA-MEDIA-2025-CINNET grant aims to support the creation and operation of a network of European cinemas. The objectives include encouraging cinema operators to screen a significant proportion of ...
Up to 500000.00 EUR
July 16, 2025, 3 p.m.
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
PAS-25-073
Jan. 7, 2028, 5 p.m.
Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)
PAR-25-315
Programme: NIH Research Project Grant
Jan. 8, 2028, 10 p.m.
Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
PAR-25-327
Oct. 8, 2027, 10 p.m.
Exploratory/Developmental Bioengineering Research Grants (EBRG)
PAR-25-346
Up to 275000.00 USD
Oct. 16, 2027, 10 p.m.
Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers
RFA-CA-25-019
Up to 499000.00 USD
Sept. 17, 2025, 10 p.m.
NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
PAR-25-032
Programme: NHLBI Clinical Trials Optimization
Up to 450000.00 USD
Oct. 16, 2026, 5 p.m.
Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
PAR-24-329
Programme: National Institutes of Health (NIH)
May 8, 2027, 10 p.m.
NEI Research Grant for Vision-Related Secondary Data Analysis
PAR-25-357
Oct. 17, 2027, 10 p.m.
441 results. Page 4 of 23.